Fast and Accurate Tools for Measuring Fluorescence in Living Cells
Fast and Accurate Tools for Measuring Fluorescence in Living Cells
批准号:
8648063
负责人:
THOMAS E HUGHES
金额:
$58.55万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-01-15 至 2015-10-31
关键词:
1,2-diacylglycerolAcetylcholineAddressAgonistAreaBasic ScienceBiologicalBiological AssayCell LineCellsCentral Nervous System DiseasesCholinergic ReceptorsColorDepositionDiabetes MellitusDiglyceridesDrug TargetingEnzymesFluorescenceFluorescence Resonance Energy TransferG Protein-Coupled Receptor SignalingG-Protein-Coupled ReceptorsGTP-Binding ProteinsGenesGoalsGreen Fluorescent ProteinsHealthHeartHeart DiseasesHumanInflammationLengthLifeMalignant NeoplasmsMaltoseMammalian CellMeasurementMeasuresMuscarinic M1 ReceptorMuscarinicsNeuronsNoisePainPathway interactionsPatternPharmaceutical PreparationsPharmacologic SubstancePhasePositioning AttributePreclinical Drug EvaluationProcessProductionProteinsReaderReceptor ActivationReproducibilitySecond Messenger SystemsSignal PathwaySignal TransductionSiteStructureSubfamily lentivirinaeSystemTestingTransgenic MiceTreatment outcomeVariantVirusbasecell typecostdrug discoveryexpression vectorheart cellhigh throughput screeningimprovedin vivomeetingsprogramsprototypepublic health relevancereceptorred fluorescent proteinresponsescreeningsecond messengersensorstable cell linestatisticstherapeutic targettool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Specific information about the state of second messengers in drug signaling pathways is key to understanding the mechanism of a drug within the cell. The largest class of drug targets is the G-Protein Coupled Receptor (GPCR) and over 40% of all prescription pharmaceuticals target a GPCR. These proteins are the focus of many drug discovery programs because they are therapeutic targets in a variety of areas including cancer, cardiac disease, diabetes, central nervous system disorders, inflammation, and pain. A critical component of many GPCR signaling pathways is the second messenger, diacylglycerol (DAG), however, there is no commercially available, robust assay for DAG that can be used in either drug screening or basic research applications. The challenge addressed by this proposal is to produce genetically-encoded robust and easy-to-use live cell assay products that can be used to study and to screen for GPCR activation. Phase I of this project demonstrated that it is feasible to produce extremely robust, genetically encoded, fluorescent sensors for DAG. This discovery is significant because despite their great advantages, the impact of genetically encoded assays on drug discovery has been limited because of poor signal to noise and low dynamic range of the response. In Phase II, the prototype sensors developed in Phase 1 will be optimized and packaged for delivery into living cells. These live cell assays will be validated under rigorous high throughput screening conditions to establish suitability for high throughput and in-vivo screening applications.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Live Cell Fluorescent Assays for SARS-CoV-2 protease activity and COVID-19 Drug Discovery
-
批准号:10480515
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2022
-
负责人:THOMAS E HUGHES
-
依托单位:
Live Cell Fluorescent Assays for SARS-CoV-2 protease activity and COVID-19 Drug Discovery
-
批准号:10621803
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2022
-
负责人:THOMAS E HUGHES
-
依托单位:
An optimized screening platform for identifying and quantifying biased agonists as drugs for the treatment of Opioid Use Disorder
-
批准号:10303305
-
项目类别:
-
资助金额:$48.21万
-
财政年份:2019
-
负责人:THOMAS E HUGHES
-
依托单位:
An optimized screening platform for identifying and quantifying biased agonists as drugs for the treatment of Opioid Use Disorder
-
批准号:10334560
-
项目类别:
-
资助金额:$31.54万
-
财政年份:2019
-
负责人:THOMAS E HUGHES
-
依托单位:
An optimized screening platform for identifying and quantifying biased agonists as drugs for the treatment of Opioid Use Disorder
-
批准号:9911512
-
项目类别:
-
资助金额:$22.11万
-
财政年份:2019
-
负责人:THOMAS E HUGHES
-
依托单位:
Fast and Accurate Tools for Measuring Fluorescence in Living Cells
-
批准号:8791351
-
项目类别:
-
资助金额:$58.24万
-
财政年份:2014
-
负责人:THOMAS E HUGHES
-
依托单位:
Genetically-Encoded Voltage Probe Development
-
批准号:8825541
-
项目类别:
-
资助金额:$55.16万
-
财政年份:2013
-
负责人:THOMAS E HUGHES
-
依托单位:
Genetically-Encoded Voltage Probe Development
-
批准号:8563391
-
项目类别:
-
资助金额:$60.49万
-
财政年份:2013
-
负责人:THOMAS E HUGHES
-
依托单位:
Genetically-Encoded Voltage Probe Development
-
批准号:8659528
-
项目类别:
-
资助金额:$59.86万
-
财政年份:2013
-
负责人:THOMAS E HUGHES
-
依托单位:
A New Modular Tool Set for Live Imaging and Manipulating the Nervous System
-
批准号:7272591
-
项目类别:
-
资助金额:$10.5万
-
财政年份:2008
-
负责人:THOMAS E HUGHES
-
依托单位:
A New Modular Tool Set for Live Imaging and Manipulating the Nervous System
-
批准号:7806067
-
项目类别:
-
资助金额:$3.67万
-
财政年份:2008
-
负责人:THOMAS E HUGHES
-
依托单位:
A New Modular Tool Set for Live Imaging and Manipulating the Nervous System
-
批准号:7623080
-
项目类别:
-
资助金额:$10.5万
-
财政年份:2008
-
负责人:THOMAS E HUGHES
-
依托单位:
Splitting GFP to look at signaling proteins
-
批准号:7244025
-
项目类别:
-
资助金额:$17.46万
-
财政年份:2006
-
负责人:THOMAS E HUGHES
-
依托单位:
Splitting GFP to look at signaling proteins
-
批准号:7143123
-
项目类别:
-
资助金额:$15.92万
-
财政年份:2006
-
负责人:THOMAS E HUGHES
-
依托单位:
Building libraries of GFP-tagged neuronal proteins
-
批准号:6685207
-
项目类别:
-
资助金额:$16.8万
-
财政年份:2002
-
负责人:THOMAS E HUGHES
-
依托单位:
Building libraries of GFP-tagged neuronal proteins
-
批准号:6557781
-
项目类别:
-
资助金额:$19.42万
-
财政年份:2002
-
负责人:THOMAS E HUGHES
-
依托单位:
Red/Green Cre recombinase reporter for retina studies
-
批准号:6531963
-
项目类别:
-
资助金额:$16.35万
-
财政年份:2002
-
负责人:THOMAS E HUGHES
-
依托单位:
TRANSMITTER/RECEPTOR-SPECIFIC CIRCUITRY IN THE RETINA
-
批准号:2162202
-
项目类别:
-
资助金额:$20.0万
-
财政年份:1993
-
负责人:THOMAS E HUGHES
-
依托单位:
TRANSMITTER/RECEPTOR-SPECIFIC CIRCUITRY IN THE RETINA
-
批准号:2162201
-
项目类别:
-
资助金额:$19.21万
-
财政年份:1993
-
负责人:THOMAS E HUGHES
-
依托单位:
TRANSMITTER/RECEPTOR-SPECIFIC CIRCUITRY IN THE RETINA
-
批准号:2162200
-
项目类别:
-
资助金额:$18.38万
-
财政年份:1993
-
负责人:THOMAS E HUGHES
-
依托单位:
海外基金